News

Confo Therapeutics

Confo Therapeutics and Daiichi Sankyo team up to tackle CNS diseases

Friday 31/03/2023

Confo Therapeutics, a spin-off from VUB, has teamed up with Daiichi Sankyo to discover and develop small molecule drugs targeting G-protein coupled receptors (GPCRs) associated with central nervous system (CNS) diseases, which are conditions that affect the brain and spinal cord.

Konligo

Building a better future, one event at a time: Konligo’s circular approach

Wednesday 29/03/2023

Konligo, a VUB spin-off, is striving to become a 100% circular company. The company creates easy-to-set-up stands for events, exhibitions, and shows, with each part of their event infrastructure being replaceable or recyclable, and produced locally with recycled resources.

Hubert Rahier recycles war debris in Ukraine

Thursday 23/03/2023

Hubert Rahier, professor of physical chemistry at the VUB Materials & Chemistry research group, has been approached by the Ukrainian company Sheldor to assist in the recycling of concrete from buildings destroyed during the Russian conflict.

Discover our new brochure: ‘A world of difference’

Tuesday 21/03/2023

Want to know how the research at the five Flemish universities improves society? And what knowledge and technology transfer looks like in practice? Our new brochure introduces you in the world of research valorisation by means of 25 striking examples! Click here to see the brochure.

Confo Therapeutics

Confo Therapeutics announces global licensing agreement with Lily

Monday 20/03/2023

Confo Therapeutics, a spin-off of VUB and VIB and a leader in the discovery of medications that target G-protein coupled receptors (GPCRs), announced a worldwide licensing agreement with Eli Lilly and Company for their clinical-stage compound CFTX-1554 and related backup compounds.

Abscint, A VUB spin-off, receives allowance for U.S. patent

Tuesday 28/02/2023

Abscint's patented technology paves the way for personalized diagnosis and therapy. Abscint, a VUB spin-off, has recently been granted a notice of allowance from the United States Patent and Trademark Office (USPTO) for its patent application.

Get to know Hugo Loosvelt

Wednesday 15/02/2023

Allow us to introduce Hugo, the IP, licensing, and spin-off manager at VUB TechTransfer. Hugo's expertise in intellectual property rights and licensing makes him a key contributor to our team's success.

Get to know Qing Cai

Thursday 19/01/2023

Meet Qing, our Business Developer at VUB TechTransfer. She specializes in helping researchers turn their applied research into products or services, specifically in the Brussels area. To get to know our team better, Qing is sharing her story today.What is your role at VUB TechTransfer?I am Business Developer for Brussels projects at VUB TechTransfer.

Vaccine

Persomed develops personalized cancer vaccine

Tuesday 20/12/2022

The Belgian start-up Persomed is developing a personalized cancer vaccine. Persomed was founded in 2020 in collaboration with VUB and 3 other partners. All of whom have expertise within the field of personalized immunotherapy.

electricity

Intelligent charging of electric vehicles

Tuesday 15/11/2022

VUB and Brussels startup Octave join hands in the CLEVER project to develop novel energy management systems for second-life battery energy storage system (BESS) in combination with intelligent charging of electric vehicles (EVs).

animab

Animab raises 10 mio euro

Monday 14/11/2022

VIB-VUB spin-off Animab, which is developing a new class of orally administered antibodies for animal health, announced the successful closing of its Series A round. The proceedings will be used to bring its lead product to market and to expand the pipeline of antibody products in animal health.

Jan Steyaert

Prestigious Gabbay Award for Jan Steyaert

Thursday 10/11/2022

Jan Steyaert, director of the VIB-VUB Center for Structural Biology and professor at Vrije Universiteit Brussel (VUB), is the first Belgian scientist to receive the prestigious Jacob and Louise Gabbay Award for outstanding science with a translational character.

First
Previous
…
10
11
12
13
14 (current)
15
16
17
18
…
Next
Last